Douglas Tsao
Stock Analyst at HC Wainwright & Co.
(2.06)
# 2,776
Out of 4,829 analysts
500
Total ratings
32.48%
Success rate
-5.27%
Average return
Main Sectors:
Stocks Rated by Douglas Tsao
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines | Reiterates: Buy | $105 | $38.35 | +173.79% | 23 | May 1, 2025 | |
| CHRS Coherus BioSciences | Reiterates: Buy | $7 | $0.97 | +622.62% | 25 | Apr 29, 2025 | |
| RZLT Rezolute | Reiterates: Buy | $14 | $3.70 | +278.38% | 17 | Apr 28, 2025 | |
| VRDN Viridian Therapeutics | Reiterates: Buy | $34 | $12.39 | +174.41% | 16 | Apr 23, 2025 | |
| ROIV Roivant Sciences | Reiterates: Buy | $18 | $10.64 | +69.17% | 18 | Apr 21, 2025 | |
| ARGX argenx SE | Reiterates: Buy | $720 | $549.27 | +31.08% | 36 | Apr 11, 2025 | |
| PTGX Protagonist Therapeutics | Reiterates: Buy | $80 | $42.95 | +86.26% | 31 | Apr 10, 2025 | |
| EOLS Evolus | Reiterates: Buy | $27 | $9.80 | +175.51% | 27 | Apr 10, 2025 | |
| ARQT Arcutis Biotherapeutics | Reiterates: Buy | $19 | $13.53 | +40.43% | 4 | Apr 3, 2025 | |
| DARE Daré Bioscience | Reiterates: Buy | $12 | $2.91 | +312.37% | 17 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $1.19 | +2,000.84% | 25 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $2.44 | +637.70% | 14 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $14.02 | +263.77% | 22 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $0.66 | +2,615.34% | 7 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $54 | $20.24 | +166.80% | 14 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $17.30 | +229.48% | 26 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $8.98 | +67.04% | 15 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $5 | $1.61 | +210.56% | 14 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $53 | $35.02 | +51.34% | 4 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $3 | $1.53 | +96.08% | 16 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $46 | $30.13 | +52.67% | 23 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $14 → $12 | $6.57 | +82.65% | 22 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $118 | $44.24 | +166.73% | 14 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $81 | $30.68 | +164.02% | 23 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $4.30 | +86.05% | 9 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $360 | $0.47 | +75,945.63% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 | $1.46 | +584.93% | 5 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $23 → $10 | $29.34 | -65.92% | 7 | Dec 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $168 → $182 | $133.96 | +35.86% | 4 | Feb 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $19 | $6.88 | +172.53% | 2 | Jan 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $25 → $18 | $22.47 | -19.89% | 3 | Aug 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $8 | $16.93 | -52.75% | 7 | Jun 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $52 | $25.12 | +107.01% | 2 | Jun 11, 2019 |
Praxis Precision Medicines
May 1, 2025
Reiterates: Buy
Price Target: $105
Current: $38.35
Upside: +173.79%
Coherus BioSciences
Apr 29, 2025
Reiterates: Buy
Price Target: $7
Current: $0.97
Upside: +622.62%
Rezolute
Apr 28, 2025
Reiterates: Buy
Price Target: $14
Current: $3.70
Upside: +278.38%
Viridian Therapeutics
Apr 23, 2025
Reiterates: Buy
Price Target: $34
Current: $12.39
Upside: +174.41%
Roivant Sciences
Apr 21, 2025
Reiterates: Buy
Price Target: $18
Current: $10.64
Upside: +69.17%
argenx SE
Apr 11, 2025
Reiterates: Buy
Price Target: $720
Current: $549.27
Upside: +31.08%
Protagonist Therapeutics
Apr 10, 2025
Reiterates: Buy
Price Target: $80
Current: $42.95
Upside: +86.26%
Evolus
Apr 10, 2025
Reiterates: Buy
Price Target: $27
Current: $9.80
Upside: +175.51%
Arcutis Biotherapeutics
Apr 3, 2025
Reiterates: Buy
Price Target: $19
Current: $13.53
Upside: +40.43%
Daré Bioscience
Apr 1, 2025
Reiterates: Buy
Price Target: $12
Current: $2.91
Upside: +312.37%
Apr 1, 2025
Reiterates: Buy
Price Target: $25
Current: $1.19
Upside: +2,000.84%
Mar 20, 2025
Reiterates: Buy
Price Target: $18
Current: $2.44
Upside: +637.70%
Mar 19, 2025
Reiterates: Buy
Price Target: $51
Current: $14.02
Upside: +263.77%
Mar 7, 2025
Reiterates: Buy
Price Target: $18
Current: $0.66
Upside: +2,615.34%
Mar 4, 2025
Reiterates: Buy
Price Target: $54
Current: $20.24
Upside: +166.80%
Mar 3, 2025
Reiterates: Buy
Price Target: $57
Current: $17.30
Upside: +229.48%
Feb 27, 2025
Reiterates: Buy
Price Target: $15
Current: $8.98
Upside: +67.04%
Feb 26, 2025
Reiterates: Neutral
Price Target: $5
Current: $1.61
Upside: +210.56%
Feb 24, 2025
Reiterates: Buy
Price Target: $53
Current: $35.02
Upside: +51.34%
Feb 18, 2025
Maintains: Buy
Price Target: $30 → $3
Current: $1.53
Upside: +96.08%
Feb 13, 2025
Reiterates: Neutral
Price Target: $46
Current: $30.13
Upside: +52.67%
Feb 12, 2025
Reiterates: Neutral
Price Target: $14 → $12
Current: $6.57
Upside: +82.65%
Jan 21, 2025
Reiterates: Buy
Price Target: $118
Current: $44.24
Upside: +166.73%
Jan 13, 2025
Reiterates: Buy
Price Target: $81
Current: $30.68
Upside: +164.02%
Nov 7, 2024
Reiterates: Buy
Price Target: $8
Current: $4.30
Upside: +86.05%
Oct 1, 2024
Reiterates: Buy
Price Target: $360
Current: $0.47
Upside: +75,945.63%
Jun 7, 2022
Downgrades: Neutral
Price Target: $10
Current: $1.46
Upside: +584.93%
Dec 9, 2021
Maintains: Neutral
Price Target: $23 → $10
Current: $29.34
Upside: -65.92%
Feb 20, 2020
Maintains: Equal-Weight
Price Target: $168 → $182
Current: $133.96
Upside: +35.86%
Jan 23, 2020
Downgrades: Neutral
Price Target: $19
Current: $6.88
Upside: +172.53%
Aug 29, 2019
Maintains: Underweight
Price Target: $25 → $18
Current: $22.47
Upside: -19.89%
Jun 11, 2019
Initiates: Underweight
Price Target: $8
Current: $16.93
Upside: -52.75%
Jun 11, 2019
Initiates: Overweight
Price Target: $52
Current: $25.12
Upside: +107.01%